Takizawa H, Suzuki N, Yanagawa T, Okazaki H, Satoh M, Akiyama N, Kohyama T, Ito K, Oka T
Department of Internal Medicine and Physical Therapy, Faculty of Medicine, University of Tokyo, Japan.
Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Nov;34(11):1177-81.
We studied length of survival and related clinical findings in 715 inpatients with collagen-vascular diseases (1984 through 1994), the diagnostic Kaplan-Meier analysis showed that patients with polymyositis/dermatomyositis and those with systemic sclerosis did not survive as long as those with other types of collagen-vascular disease. Of the patients who died 37% died of respiratory failure due to interstitial lung disease. Patients with interstitial lung disease had better outcomes than did those with idiopathic interstitial pneumonia: they were younger, had higher initial vital capacities, and fewer episodes of acute exacerbation of lung disease than did those with idiopathic interstitial pneumonia. Among patients with interstitial lung disease, those who died of polymyositis/dermatomyositis did so within 1 year, but those who died of systemic sclerosis lived longer. Interstitial lung disease is an important prognostic factor in collagen-vascular disease, and needs further evaluation.
我们研究了1984年至1994年间715例胶原血管病住院患者的生存时间及相关临床发现。诊断性的Kaplan-Meier分析显示,多发性肌炎/皮肌炎患者和系统性硬化症患者的存活时间不如其他类型胶原血管病患者长。在死亡患者中,37%死于间质性肺病导致的呼吸衰竭。与特发性间质性肺炎患者相比,间质性肺病患者的预后更好:他们更年轻,初始肺活量更高,肺部疾病急性加重发作次数更少。在间质性肺病患者中,死于多发性肌炎/皮肌炎的患者在1年内死亡,但死于系统性硬化症的患者存活时间更长。间质性肺病是胶原血管病的一个重要预后因素,需要进一步评估。